statins
Vitamin C Saga: How a small expert group fought back against NHS misinformation
3By Jerome Burne Whenever government […]
The cholesterol-lowering juggernaut that is trundling towards you
8By Jerome Burne Sometime next […]
Cholesterol is innocent. How the real killers were tracked down
35By Jerome Burne A murder mystery […]
Massive statin trial that aims to silence all the critics. The iron fist in an evidence-based glove.
24Last week a massive piece of research extolling the benefits of statins was published in the Lancet. Its headline message was that the benefits of statins are hugely underestimated and far outweigh any harm. It had found that only 2 people per hundred suffer side effects while 15 people per hundred avoid strokes and heart attacks.
It came garlanded with the full majesty of the medical profession. Thirty pages long with 28 authors, 300 references and a declaration of interests that filled 44 lines of small type and mentioned more than 20 of the largest pharmaceutical companies. This juggernaut was designed to bury the widely publicised doubts about the effectiveness and safety of these drugs already prescribed to 6 million people.
How senior medics use strong arm tactics to close down the debate on statin side effects
11One of the alarming and intriguing things about the cholesterol lowering drugs statins is the vigour and ferocity with which supporters defend them. It’s alarming because it makes it almost impossible for both doctors and patients to get accurate information about their risks and benefits. Intriguing because it is so unscientific.
Companies clash over statin side effects. Which is lying?
18The complicated and confusing debate about statins – are they worth taking or not; are they safe or do they have nasty side effect? – has suddenly plunged into anarchic and uncharted territory by the claims of a new rival drug.
Recent Comments